Detlev Mennerich

Director/Miembro de la Junta en

NBE-Therapeutics AG

57 años

16 relaciones

Health Technology

Consumer Services

Commercial Services

Perfil

Detlev Mennerich is currently Director at NBE-Therapeutics AG, TACALYX GmbH, and T-Knife GmbH.
Formerly, Dr. Mennerich was Corporate Senior Vice President at Boehringer Ingelheim International GmbH from 2022 to 2025, Director at Rinri Therapeutics Ltd., and Chairman-Supervisory Board at Topas Therapeutics GmbH.
Education includes an undergraduate degree from Technische Universität Braunschweig in 1997 and a doctorate from Martin-Luther-Universität Halle-Wittenberg in 2000.

Cargos activos de Detlev Mennerich

Empresas	Cargo	Inicio
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Inversor de Capital Privado	01/01/2014
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Director/Miembro de la Junta	-
NBE-Therapeutics AG NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies	Director/Miembro de la Junta	-
T-Knife GmbH T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer	Director/Miembro de la Junta	-

Todos los cargos activos de Detlev Mennerich

Antiguos cargos conocidos de Detlev Mennerich.

Empresas	Cargo	Fin
Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals	Corporate Officer/Principal	01/01/2025
Topas Therapeutics GmbH Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for immune tolerance	Presidente	-
Rinri Therapeutics Ltd. Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Detlev Mennerich.

Formación de Detlev Mennerich.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Detlev Mennerich.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	9
Technische Universität Braunschweig Technische Universität Braunschweig Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Martin-Luther-Universität Halle-Wittenberg Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and marketing of medicines for humans & animals	Health Technology
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Finance
NBE-Therapeutics AG NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies	Health Technology
Topas Therapeutics GmbH Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for immune tolerance	Health Technology
Rinri Therapeutics Ltd. Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss	Commercial Services
TACALYX GmbH TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services Develops therapeutics targeting cancer-specific carbohydrate antigens for metastatic malignant tumors	Commercial Services
T-Knife GmbH T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer	Health Technology